These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14242733)

  • 1. [CLINICAL RESULTS OBTAINED BY THE USE OF ANTIFIBRINOLYTIC AGENT].
    LENOIR P; TURPIN J; PAWLOTSKY Y; NOURY S; GOUFFAULT J; BOUREL M
    Therapie; 1964; 19():1651-6. PubMed ID: 14242733
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICAL EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID AS AN ANTIFIBRINOLYTIC AGENT IN VARIOUS OBSTETRICAL DISORDERS].
    PALACIO S; CANO A; YEPES E
    Rev Colomb Obstet Ginecol; 1964; 15():413-9. PubMed ID: 14258173
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE THERAPEUTIC USE OF EPSILON-AMINOCAPROIC ACID AND OTHER ANTIFIBRINOLYTICS].
    PERLICK E
    Dtsch Gesundheitsw; 1964 May; 19():900-3. PubMed ID: 14220146
    [No Abstract]   [Full Text] [Related]  

  • 4. [AN EFFECTIVE ANTIFIBRINOLYTIC AGENT: EPSILON-AMINOCAPROIC ACID].
    GROSSI F
    Clin Ter; 1963 Jul; 26():73-8. PubMed ID: 14050038
    [No Abstract]   [Full Text] [Related]  

  • 5. AN ANTIFIBRINOLYTIC AGENT: AMINOCAPROIC ACID.
    COVENTRY MB
    JAMA; 1965 Feb; 191():489-90. PubMed ID: 14238032
    [No Abstract]   [Full Text] [Related]  

  • 6. [NEW PHARMACOLOGIC PRODUCTS. 3. THE ANTIFIBRINOLYTIC AGENT EPSILON-AMINOCAPROIC ACID].
    STRIEGLER G
    Pharm Prax; 1964; 11():256-8. PubMed ID: 14317099
    [No Abstract]   [Full Text] [Related]  

  • 7. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 8. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 9. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 10. [A NEW METHOD OF THE ANALYSIS OF EPSILON-AMINOCAPROIC ACID (EACA) AND AMINOMETHYLCYCLOHEXANE CARBOXYLIC ACID (AMCHA), THE POTENT ANTIFIBRINOLYTIC AGENTS].
    TAKATA Y; TAKATA A; OKAMOTO U
    Nihon Seirigaku Zasshi; 1964 May; 26():281-5. PubMed ID: 14172890
    [No Abstract]   [Full Text] [Related]  

  • 11. [ANTIFIBRINOLYTIC AGENTS].
    ZWEIBAUM A; JOSSO F
    Rev Prat; 1963 Dec; 13():SUPPL 135-8. PubMed ID: 14099272
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of postprostatectomy bleeding by epsilon-aminocaproic acid.
    Sack E; Spaet TH; Gentile RL; Hudson PB
    N Engl J Med; 1962 Mar; 266():541-3. PubMed ID: 14495863
    [No Abstract]   [Full Text] [Related]  

  • 13. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and antifibrinolytic activity of dipeptides of E-aminocaproic acid and sulfur-containing amino acids].
    Midura-Nowaczek K; Bruzgo I; Radzajewska B; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1988; 45(1):35-41. PubMed ID: 3421139
    [No Abstract]   [Full Text] [Related]  

  • 15. xi-Aminocaproic acid: an inhibitor of plasminogen activation.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Biol Chem; 1959 Apr; 234(4):832-7. PubMed ID: 13654273
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTIFIBRINOLYTIC TREATMENT WITH EPSILON-AMINOCAPROIC ACID IN CONNECTION WITH PROSTATECTOMY.
    ANDERSSON L
    Acta Chir Scand; 1964 May; 127():552-64. PubMed ID: 14169785
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE PHARMACOLOGIC PROPERTIES OF A NEW ANTIFIBRINOLYTIC, PARA-AMINOMETHYLBENZOIC ACID].
    MARKWARDT F; HAUSTEIN KO; KLOECKING HP
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():223-33. PubMed ID: 14248348
    [No Abstract]   [Full Text] [Related]  

  • 18. [ANTIPLASMIN DRUGS].
    MATSUOKA S; OGUCHI G
    Sogo Rinsho; 1963 Oct; 12():1986-91. PubMed ID: 14092546
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE ROLE OF EPSILON-AMINOCAPROIC ACID IN FIBRINOLYTIC STATES].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M; CASUBOLO L
    Rev Clin Esp; 1964 Oct; 95():17-21. PubMed ID: 14234364
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECTS OF SOME AMINO ACIDS ON THE INHIBITION OF PLASMIN BY ANTIPLASMIN.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Biochim Biophys Acta; 1965 May; 99():342-51. PubMed ID: 14336071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.